Articles

STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy
Laboratory for Technologies of Advanced Therapies (LTTA) and Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
Laboratory of Functional Genomics, Institute for Cancer Research and Treatment, University of Turin, Italy
Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy;Department of Oncology, University of Turin, Italy
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Molecular Biotechnology Center, University of Turin, Italy
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Molecular Biotechnology Center, University of Turin, Italy
Laboratory of Functional Genomics, Institute for Cancer Research and Treatment, University of Turin, Italy
Laboratory for Technologies of Advanced Therapies (LTTA) and Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy;Department of Pathology, and NYU Cancer Center, New York University School of Medicine, New York, NY, USA
Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy;Center for Experimental Research and Medical Studies (CeRMS), Turin, Italy;Department of Pathology, and NYU Cancer Center, New York University School of Medicine, New York, NY, USA
Vol. 99 No. 1 (2014): January, 2014 https://doi.org/10.3324/haematol.2013.088286